| Stage | KFRC | % of rev | IRMD | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $358M | 100.00% | $24M | 100.00% | KFRC ×14.78 |
| Gross profit | $101M | 28.19% | $18M | 76.26% | IRMD +48.1pp |
| Operating income | $23M | 6.29% | $8M | 33.63% | IRMD +27.3pp |
| Pre-tax income | $22M | 6.05% | $9M | 35.81% | IRMD +29.8pp |
| Net income | $15M | 4.32% | $7M | 26.88% | IRMD +22.6pp |
| Stage | KFRC | IRMD | Gap · A − B |
|---|---|---|---|
| Revenue | $358M100.00% | $24M100.00% | KFRC ×14.78 |
| Gross profit | 28.19%$101M | 76.26%$18M | IRMD +48.1pp |
| Operating income | 6.29%$23M | 33.63%$8M | IRMD +27.3pp |
| Pre-tax income | 6.05%$22M | 35.81%$9M | IRMD +29.8pp |
| Net income |
| 4.32%$15M |
| 26.88%$7M |
| IRMD +22.6pp |
No shared counterparties.